Review of the phenotypes and genotypes of Bardet-Biedl syndrome from China

Z Xin-Yi, D Yang-Li, Z Ling-Hui - Frontiers in Genetics, 2023 - frontiersin.org
Objective: To analyze the phenotypes, genotypes, and the relationship of phenotypes and
genotypes for Chinese patients with Bardet-Biedl syndrome (BBS). Methods: The Chinese …

Contribution of intraflagellar transport to compartmentalization and maintenance of the photoreceptor cell

TR Lewis, CM Castillo, NV Klementieva, Y Hsu… - Proceedings of the …, 2024 - pnas.org
The first steps of vision take place in the ciliary outer segment compartment of photoreceptor
cells. The protein composition of outer segments is uniquely suited to perform this function …

Bardet‐Biedl syndrome: A clinical overview focusing on diagnosis, outcomes and best‐practice management

A Shoemaker - Diabetes, Obesity and Metabolism, 2024 - Wiley Online Library
Bardet‐Biedl syndrome (BBS) is a genetic disorder characterized by early‐onset obesity,
polydactyly, genital and kidney anomalies, developmental delay and vision loss due to rod …

Dual AAV-based PCDH15 gene therapy achieves sustained rescue of visual function in a mouse model of Usher syndrome 1F

S Riaz, S Sethna, T Duncan, MA Naeem… - Molecular Therapy, 2023 - cell.com
Mutations in the PCDH15 gene, encoding protocadherin-15, are among the leading causes
of Usher syndrome type 1 (USH1F), and account for up to 12% USH1 cases worldwide. A …

Fine-tuning FAM161A gene augmentation therapy to restore retinal function

Y Arsenijevic, N Chang, O Mercey… - EMBO Molecular …, 2024 - embopress.org
For 15 years, gene therapy has been viewed as a beacon of hope for inherited retinal
diseases. Many preclinical investigations have centered around vectors with maximal gene …

[PDF][PDF] A visually guided swim assay for mouse models of human retinal disease recapitulates the multi-luminance mobility test in humans

S Hassan, Y Hsu, SK Mayer, J Thomas… - Saudi Journal of …, 2023 - journals.lww.com
PURPOSE: The purpose of this study was to develop a visually guided swim assay (VGSA)
for measuring vision in mouse retinal disease models comparable to the multi-luminance …

IMPC impact on preclinical mouse models

SM Hölter, P Cacheiro, D Smedley, KC Kent Lloyd - Mammalian Genome, 2025 - Springer
SM Hölter et al. to expand preclinical knowledge on a variety of diseases and disorders,
including cardiac dysfunction (Guo et al. 2018; Wang et al. 2019; Spielmann et al. 2022) …

An osmolarity dependent mechanism partially ameliorates retinal cysts and rescues cone function in a mouse model of X-linked retinoschisis

EJ Gehrke, J Thompson, E Kalmanek… - Frontiers in …, 2024 - frontiersin.org
Introduction X-linked retinoschisis (XLRS) is a vitreoretinal dystrophy caused by RS1 gene
mutations which disrupt retinoschisin-1 (RS1) function. Vital for retinal architecture, the …

The dose-response relationship of subretinal gene therapy with rAAV2tYF-CB-hRS1 in a mouse model of X-linked retinoschisis

S Hassan, Y Hsu, JM Thompson, E Kalmanek… - Frontiers in …, 2024 - frontiersin.org
Purpose X-linked retinoschisis (XLRS), due to loss-of-function mutations in the retinoschisin
(RS1) gene, is characterized by a modest to severe decrease in visual acuity. Clinical trials …

Investigating the role of Caspase-1 in a mouse model of Juvenile X-linked Retinoschisis

EJ Gehrke, A Pandey, J Thompson, S Bhattarai… - Frontiers in …, 2024 - frontiersin.org
Purpose Previous studies have reported Caspase-1 (Casp1) is upregulated in mouse
models of Juvenile X-linked Retinoschisis (XLRS), however no functional role for Casp1 in …